Adare Pharmaceuticals:Product out-licensing opportunities to enhance your portfolio

 Is your company trying to expand its expertise into other therapeutic categories? Are you looking to grow your product portfolio? Adare has a diverse portfolio of products available for out-licensing. 


 

Is your company trying to expand its expertise into other therapeutic categories? Are you looking to grow your product portfolio? Adare has a diverse portfolio of products available for out-licensing.

 

Using our proprietary drug delivery technologies, we’ve created new formulations of Rx and OTC products with proven patient benefits. We out-license these products to pharmaceutical companies for commercialization around the world.

 

Here are just a few of our products that are available for out-licensing in select territories:

  • Cyclobenzaprine ER 15 mg, 30 mg Extended Release Capsules 
  • A once-daily formulation of muscle relaxant that provides a very low rate of somnolence/daytime drowsiness

  • Incorporates Diffucaps® Customized Release Technology

  • Diphenhydramine ODT 25 mg Orally Disintegrating Tablets
  • An oral anti-histamine that also treats insomnia-formulated as a convenient, easy-to-swallow ODT

  • Incorporates Microcaps® Taste Masking Technology and AdvaTab® Orally Disintegrating Tablets

  • InnoPran XL® (propranolol HCl) 80 mg, 120 mg Extended Release Capsules
  • A beta-adrenergic blocker indicated for the treatment of hypertension to lower blood pressure

  • Incorporates Diffucaps® Customized Release Technology

 

To learn more about additional product out-licensing opportunities, contact Lisa.Miller@adarepharma.com or visit www.AdarePharma.com.

 

©2015 Adare Pharmaceuticals, Inc.